文献速递产科

低风险初产妇39周引产的伦理问题:研究与临床实践中的探讨

The ethics of induction of labor at 39 weeks in low-risk nulliparas in research and clinical practice.
PubMed 文献 · Am J Obstet Gynecol · 2023-08-24

本文讨论低风险初产妇39周 elective 引产在随机试验与临床实践中的伦理问题。作者分析现有证据后认为,该领域需进一步研究,孕期自主性脆弱时知情同意需警惕,分娩不仅是医学对象也是社会现象,需纳入女性视角。

要点

  • ARRIVE试验提示39周引产可考虑为低风险初产妇的合理选择,但外部效度不足。
  • 法国ARRIVE试验正在不同环境中验证39周 elective 引产能否降低剖宫产率。
  • 作者认为该领域需进一步研究,知情同意在孕期自主性脆弱时需警惕。

核心结论

  • 现有证据分析表明,低风险女性39周引产需进一步研究。
  • 该领域研究伦理中,孕期自主性脆弱背景下的知情同意需保持警惕。
  • 分娩不仅是医学对象,也是不能仅从健康风险角度看待的社会现象。
  • 该问题需进一步研究以让孕妇做出知情决策,结果应与 social issues 整合。
  • 构建、评估和实施分娩医学干预(如39周引产)需要女性视角。

研究设计与样本

  • 本文为伦理分析,讨论低风险初产妇39周 elective 引产的随机试验与临床实践伦理问题。
  • 分析基于现有证据,包括2018年发表的ARRIVE试验及正在进行的法国ARRIVE试验。

主要发现

  • 2018年ARRIVE试验提示39周引产可考虑为低风险初产妇的合理选择。
  • 部分专业学会认可39周 elective 引产选项,已开始改变产科实践。
  • ARRIVE试验因外部效度担忧,不足以作为广泛39周 elective 引产的主要依据。
  • 法国ARRIVE试验设计检验39周 elective 引产剖宫产率低于期待管理的假设。
  • 该进行中试验被批评为伪科学及告诉女性分娩地点、时间和方式,作者拒绝这些指控。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The "A Randomized Trial of Induction Versus Expectant Management" trial (ARRIVE trial) published in 2018 suggested that induction of labor can be considered a "reasonable option" for low-risk nulliparous women at ≥39 weeks of gestation. The study results led some professional societies to endorse the option for elective induction of labor at 39 weeks of gestation in low-risk nulliparas, and this has begun to change obstetrical practice. The ARRIVE trial provided valuable information supporting the benefits of induction of labor; however, the trial is insufficient to serve as the primary justification for widespread elective induction of labor at 39 weeks of gestation in low-risk nulliparas because of concerns about external validity. Thus, the French ARRIVE trial was designed to test the hypothesis in a different setting that elective induction of labor at 39 weeks of gestation in low-risk nulliparas leads to a lower cesarean delivery rate than expectant management. This ongoing trial has been criticized as "pseudoscientific" and telling "women where, when, and how to give birth." We reject these allegations and extensively examine the ethical framework that should govern clinical and research interventions, including elective induction of labor at 39 weeks of gestation in low-risk nulliparas. This study aimed to discuss the ethical issues that emerge from randomized trials of elective induction of labor at 39 weeks of gestation in low-risk nulliparas and the ethics of the clinical practice itself. The analysis of existing evidence shows the importance of further research on induction of labor at 39 weeks of gestation in low-risk women. Certain aspects of research ethics in this area, particularly the consent of pregnant women in a context where autonomy remains fragile, call for vigilance. In addition, we emphasize that childbirth is not only a medical object but also a social phenomenon that cannot be regarded only from the perspective of a health risk to be managed by clinical research. Further research on this issue is needed to allow pregnant women to make informed decisions, and the results should be integrated with social issues. The perspective of women is required in constructing, evaluating, and implementing medical interventions in childbirth, such as induction of labor at 39 weeks of gestation.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Azria E, Haaser T, Schmitz T, et al. The ethics of induction of labor at 39 weeks in low-risk nulliparas in research and clinical practice. Am J Obstet Gynecol. 2023. PMID: 37633577. doi:10.1016/j.ajog.2023.07.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。